missing translation for 'onlineSavingsMsg'
Learn More

R&D Systems™ Dasatinib

Product Code. 18708146
Change view
Click to view available options
Quantity:
100 mg
Unit Size:
100mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Product Code. Quantity Unit Size
18708146 100 mg 100mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Product Code. 18708146 Supplier R&D Systems™ Supplier No. 6793/100
  • ONLINE EXCLUSIVE PRICE
    181.00€
    171.15€ / 100mg
    Save 9.85€
    5% Off
 Restricted Item
Estimated Shipment: 29-10-2026
Add to basket
Add to basket

missing translation for 'validMainframeMsg'

This item is not returnable. View return policy

A Tocris product, part of R&D Systems. Highly potent pan-Src/Bcr-Abl inhibitor

Dasatinib is a highly potent pan-Src/Bcr-Abl inhibitor (Ki values are 16 and 30 pM, respectively. Inhibits Bcr-Abl, Src, Lck, Fyn, c-kit and Yes with IC50 values in the subnanomolar range. Inhibits proliferation of tumor cells in vitro and exhibits anticancer acivity in vivo in a mouse chronic myelogenous leukemia (CML) xenograft model. Inhibits replication of SARS-CoV and MERS-CoV in vitro (EC50 values are 2.1and 5.5 μM, respectively). Dasatinib also enhances CD3-targeted lentiviral vector-mediated gene transfer by 3 to 10-fold.
TRUSTED_SUSTAINABILITY

Specifications

Chemical Name or Material N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide
CAS 302962-49-8
Synonym BMS-354825
Quantity 100 mg
Product Line Tocris
Molecular Formula C22H26ClN7O2S
Formula Weight 488.01
Purity 98%
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.